Literature DB >> 19390901

Pretreatment assessment of resectable and borderline resectable pancreatic cancer: expert consensus statement by Callery et al.

Michael A Choti1, Elijah Dixon, Douglas Tyler.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19390901     DOI： 10.1245/s10434-009-0411-y

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN： 1068-9265            Impact factor:   5.344


× No keyword cloud information.
  4 in total

1.  A Visualized Dynamic Prediction Model for Overall Survival in Elderly Patients With Pancreatic Cancer for Smart Medical Services.

Authors:  Jiang Zhong; XingShu Liao; Shuang Peng; Junyi Cao; Yue Liu; Chunyang Liu; Ju Qiu; Xiaoyan Guan; Yang Zhang; Xiaozhu Liu; Shengxian Peng
Journal:  Front Public Health       Date:  2022-05-24

2.  Prognostic factors and sites of metastasis in unresectable locally advanced pancreatic cancer.

Authors:  Renata D'Alpino Peixoto; Caroline Speers; Colleen E McGahan; Daniel J Renouf; David F Schaeffer; Hagen F Kennecke
Journal:  Cancer Med       Date:  2015-04-18       Impact factor: 4.452

3.  HIFU is safe, effective, and feasible in pancreatic cancer patients: a monocentric retrospective study among 523 patients.

Authors:  Zhouyu Ning; Jing Xie; Qiwen Chen; Chenyue Zhang; Litao Xu; Libin Song; Zhiqiang Meng
Journal:  Onco Targets Ther       Date:  2019-02-01       Impact factor: 4.147

4.  Serum cytokine biomarker panels for discriminating pancreatic cancer from benign pancreatic disease.

Authors:  Victoria E Shaw; Brian Lane; Claire Jenkinson; Trevor Cox; William Greenhalf; Christopher M Halloran; Joseph Tang; Robert Sutton; John P Neoptolemos; Eithne Costello
Journal:  Mol Cancer       Date:  2014-05-20       Impact factor: 27.401
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.